Summary
Susceptibility to metronidazole of 213 clinical strains ofH. pylori from dyspeptic patients was determined by a plate dilution method. Seventy two (33.8%) of the strains were resistant to metronidazole (MIC > 8 mg/L), 20 of these were from 24 patients who had received previously metronidazole (83.3%), giving a primary (pretreatment) resistance rate of 27.5% (52/189). The resistance rate was higher in women than in men, especially aged 50 to 59 years old (43.6% vs 23.3%, p<0.001). The resistance rate was lower in patients at 60 or over (9.8%), but similar between the younger patients groups (38.8% - 49.0%). There was no difference in the resistance rate between peptic ulcer disease (32.6%) and nonulcer dyspepsia (34.7%). These data indicated that metronidazole resistance inH. pylori is absolutely associated with previous use of the drug, and the higher resistance rate in women may be due to the more frequent prescription of the drug for their gynaecological infection or operation. Therefore, testing of susceptibility ofH. pylori to metronidazole is important. A new susceptibility testing technique, the E-test was evaluated in this study and found to give comparable results to the plate dilution method and also had the advantage of being simple to perform.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Patchett, S., Beattie, S., Leen, E., Keane, C., O’Morain, C.Helicobacter pylori and duodenal ulcer recurrence. Am. J. Gastroenterol. 1992: 87. 24–27.
Rauws, E. A., Tytgat, G. N. J. Cure of duodenal ulcer associated with eradication ofHelicobacter pylori. Lancet 1990: 335, 1233–35.
Marshall, B. J., Goodwin, C. S., Warren, J. R., Murragh, R., Blincow, E. D., Blackbourn, S. J.et al. Prospective double-blind trial of duodenal ulcer relapse after eradication ofCampylobacter pylori. Lancet 1988: ii, 1437–42.
Weil, J., Bell, G. D., Powell, K., Morden, A., Harrison, G., Gant, P. W.et al. Helicobacter pylori infection treated with a tripotassium dicitrate bismuthate and metronidazole combination. Aliment. Pharmacol. Therap. 1990: 4, 651–57.
Glupczynski, Y., Burette, A., de Koster, E., Nyst, J. F., Deltner, M., Cadranel, S.et al. Metronidazole resistance inHelicobacter pylori. Lancet 1990: 335, 976–77.
Mathai, E., O’Riordan, T., Tobin, A., Beattie, S., Cafferky, M., O’Morain, C. Drug resistance inHelicobacter pylori. In: Malfertheiner, P., Ditsuchneit, H. (Eds.).Helicobacter pylori and peptic ulcer, Berlin, Germany: Springer-Verlag. 1990: 395–401.
Xia, H. X., Daw, M. A., Beattie, S., Keane, C. T., O’Morain, C. A. The influence of metronidazole resistance on triple therapy forHelicobacter pylori associated duodenal ulcer. Gastroenterol. 1992: 102(4) A947.
National Committee for Clinical Laboratory Standards. 1990. Standard MF-A National Committee for Clinical Laboratory Standards, Villanova, Pa.
Goodwin, C. S., Marshall, B. J., Blincow, E. D., Wilson, D. H., Blackbourn, S., Phillips, M. Prevention of nitroimidazole resistancein Helicobacter pyloriby coadministration of colloidal bismuth subcitrate: clinical andin vitro studies. J. Clin. Pathol. 1988: 41, 207–10.
Becx, M. C. J. M., Janssen, A. J. H. M., Clasener, H. A. L., De Koning, R. W. Metronidazole-resistantHelicobacter pylori. Lancet 1990: 335, 539–40.
Rautelin, H., Seppala, K., Renkonen, O-V., Vaino, U., Kosunen, T. U. Role of metronidazole resistance in therapy ofHelicobacter pylori infections. Antimicrob. Agents Chemother. 1992: 36, 163–66.
Xia, H. X., Daw, M. A., Keane, C. T., O’Morain, C. A.Helicobacter pylori: emergence of metronidazole-resistance isolates. J. Med. Microbiol. 1991: 35, ix (abstract).
Xia, H. X., Daw, M. A., Keane, C. T., O’Morain, C. A. Inductionof Helicobacter pylori resistance to metronidazole and tetracyclinein vitro. Ital. J. Gastroenterol. 1991: 23 (Suppl. 2), 49 (abstract).
Metronidazole. In: Kucers, A., Bennett, N. Mck. The use of antibiotics. (Fourth edition), Heinemann, London. 1987: 1290–329.
Bell, G. D., Powell, K., Burridge, S. M., Pallecaros, A., Jones, P. H., Gant.P. W.et al. Experience with the ‘triple’ anti-Helicobacterpylori eradication therapy: side effects and the importance of testing and pre-treatment bacterial isolate for metronidazole resistance. Aliment. Pharmacol. Therap. 1992: 6, 427–435
Goodwin, C. S., Blake, P., Blincow, E. The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents againstCampylobacter pyloridis. J. Antimicrob. Chemother. 1986: 17, 309–314.
Knapp, C. C., Ludwig, M. D., Washington, J. A.In vitro activity of metronidazole againstHelicobacter pylori as determined by agar dilution and agar diffusion. Antimicrob. Agents Chemother. 1991: 35, 1230–31.
Baker, C. N., Stocker, S. A., Culver, D.H., Thornsberry, C. Comparison of the E-test to Agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. J. Clin. Microbiol. 1991: 29, 533–38.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Xia, H.X., Daw, M.A., Beattie, S. et al. Prevalence of metronidazole-resistant helicobacter pylori in dyspeptic patients. I.J.M.S. 162, 91–94 (1993). https://doi.org/10.1007/BF02942098
Issue Date:
DOI: https://doi.org/10.1007/BF02942098